| Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphoma SE Arthur, A Jiang, BM Grande, M Alcaide, R Cojocaru, CK Rushton, ... Nature communications 9 (1), 1-14, 2018 | 145 | 2018 |
| Genetic inactivation of TRAF3 in canine and human B-cell lymphoma KR Bushell, Y Kim, FC Chan, S Ben-Neriah, A Jenks, M Alcaide, ... Blood, The Journal of the American Society of Hematology 125 (6), 999-1005, 2015 | 84 | 2015 |
| Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphoma CK Rushton, SE Arthur, M Alcaide, M Cheung, A Jiang, KM Coyle, ... Blood advances 4 (13), 2886-2898, 2020 | 71 | 2020 |
| Molecular profiling in diffuse large B‐cell lymphoma: why so many types of subtypes? RD Morin, SE Arthur, DJ Hodson British Journal of Haematology 196 (4), 814-829, 2022 | 70 | 2022 |
| Coding and noncoding drivers of mantle cell lymphoma identified through exome and genome sequencing P Pararajalingam, KM Coyle, SE Arthur, N Thomas, M Alcaide, ... Blood, The Journal of the American Society of Hematology 136 (5), 572-584, 2020 | 58 | 2020 |
| A novel multiplex droplet digital PCR assay to identify and quantify KRAS mutations in clinical specimens M Alcaide, M Cheung, K Bushell, SE Arthur, HL Wong, J Karasinska, ... The Journal of Molecular Diagnostics 21 (2), 214-227, 2019 | 37 | 2019 |
| Targeted error-suppressed quantification of circulating tumor DNA using semi-degenerate barcoded adapters and biotinylated baits M Alcaide, S Yu, J Davidson, M Albuquerque, K Bushell, D Fornika, ... Scientific reports 7 (1), 10574, 2017 | 28 | 2017 |
| Treating lymphoma is now a bit EZ-er RD Morin, SE Arthur, S Assouline Blood Advances 5 (8), 2256-2263, 2021 | 27 | 2021 |
| Shared and distinct genetic features in human and canine B-cell lymphomas KM Coyle, T Hillman, M Cheung, BM Grande, KR Bushell, SE Arthur, ... Blood Advances 6 (11), 3404-3409, 2022 | 7 | 2022 |
| Non-coding NFKBIZ 3′ UTR mutations promote cell growth and resistance to targeted therapeutics in diffuse large B-cell lymphoma SE Arthur, J Gao, S Healy, CK Rushton, N Thomas, LK Hilton, K Dreval, ... bioRxiv, 2021.05. 22.445261, 2021 | 3 | 2021 |
| IDENTIFYING MUTATIONS ENRICHED IN RELAPSED‐REFRACTORY DLBCL TO DERIVE GENETIC FACTORS UNDERLYING TREATMENT RESISTANCE C Rushton, M Alcaide, M Cheung, N Thomas, S Arthur, N Michaud, ... Hematological Oncology 37, 35-36, 2019 | 3 | 2019 |
| Deleuze and Lola Montès R Rushton Bloomsbury Publishing USA, 2020 | 2 | 2020 |
| Recurrent patterns of clonal evolution in relapsed-refractory DLBCL following treatment with R-CHOP C Rushton, SE Arthur, M Alcaide, M Cheung, N Thomas, LK Hilton, ... Blood 134, 921, 2019 | 2 | 2019 |
| An Open-Source Toolkit That Powers the Genome-Wide Analysis of Mature B-Cell Lymphomas (GAMBL) Project K Dreval, BM Grande, H Winata, J Wong, L Sethi, CK Rushton, ... Blood 138, 1873, 2021 | 1 | 2021 |
| Nfkbiz 3′ UTR Mutations Confer Selective Growth Advantage and Affect Drug Response in Diffuse Large B-Cell Lymphoma SE Arthur, N Thomas, C Rushton, J Tang, M Alcaide, S Healy, A Telenius, ... Blood 136, 31, 2020 | 1 | 2020 |
| Shared and Distinct Genetic Features in Human and Canine B-Cell Lymphomas T Hillman, M Cheung, BM Grande, KR Bushell, SE Arthur, M Alcaide, ... Blood 138, 3509, 2021 | | 2021 |
| Discovery and characterization of novel non-coding 3′ UTR mutations in NFKBIZ and their functional implications in diffuse large B-cell lymphoma S Arthur Simon Fraser University, 2021 | | 2021 |
| Abstract PO-32: NFKBIZ 3′ UTR mutations confer selective growth advantage and affect drug response in diffuse large B-cell lymphoma SE Arthur, N Thomas, J Tang, CK Rushton, M Alcaide, A Telenius, ... Blood Cancer Discovery 1 (3_Supplement), PO-32-PO-32, 2020 | | 2020 |
| Abstract IA42: Detecting and quantifying mutations associated with treatment resistance in aggressive lymphomas using ctDNA N Thomas, LK Hilton, N Michaud, K Bushell, R Rys, M Jain, L Shepherd, ... Blood Cancer Discovery 1 (3_Supplement), IA42-IA42, 2020 | | 2020 |
| NFKBIZ3′ UTR Mutations Confer Selective Growth Advantage and Activate Genes with Therapeutic Implications in Diffuse Large B-Cell Lymphoma SE Arthur, N Thomas, C Rushton, M Alcaide, S Healy, A Mottok, DW Scott, ... Blood 134, 296, 2019 | | 2019 |
